Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by 88STR8Ton Jun 03, 2018 11:08am

146 Views

Post# 28117048

new slide presentation of May 28

it looks like most of the same stuff except they quote " One patient with Cell Pouch™ and cells implanted over 3.5 years"

also, transactions in the industry

Semma • Series B Financing for $114M
• Based on their annual report, about 30M shares issued. $3.80 a share
• With approximately 70M shares outstanding Preferred and Common, market cap of $266M

Bullboard Posts

Geologica Resource: Polymetallic upside at a depressed price